OMNECOIL INSTRUMENTS, INC.

Medtech · Private

Endorectal MRI coil and needle guide system for prostate imaging and biopsy

Grants
$881K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Combined endorectal prostatic Magnetic Resonance Imaging and Biopsy Device to Enable Single Combined Procedures$224,996
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Prostate cancer diagnosis with an integrated endorectal MRI and targeted transrectal biopsy$255,787
Federal grantDepartment of Health and Human Services · Phase I · Transforming prostate cancer diagnosis: Feasibility testing of a novel system for integrated endorectal MRI and in-bore biopsy$399,995
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1584NEOVATIVE, INC.——
1585Revive Biotechnology Inc.——
1586VIVID TECHNOLOGIES INC——
1587OMNECOIL INSTRUMENTS, INC.——
1588Pontosense Inc.—$4.4M
1589NOVIS PRODUCTS, LLC——
1590NIRMIDAS BIOTECH, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.